The goal of the annual Dermatology - Rheumatology Collaborative is to improve education for trainees and practicing dermatologists and rheumatologists in early identification of psoriatic arthritis and the value of collaborative care for patients with psoriatic disease. The 2022 Dermatology Rheumatology Collaborative symposium will take place Saturday April 23 in Chicago, IL.
By the end the event, participants will be able to:
- Understand appropriate diagnosis of psoriasis and psoriatic arthritis symptoms from cross-disciplinary perspectives to ensure early intervention
- Understand and implement both:
o The newly updated joint American Academy of Dermatology - National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis, including guidelines for comorbidities, pediatrics, phototherapy, systemics, biologics and topicals
o The newly released American College of Rheumatology - National Psoriasis Foundation guidelines for the treatment of psoriatic arthritis
- Delineate the spectrum of comorbidities associated with psoriasis and psoriatic arthritis and institute treatment plans aimed at minimizing their impact
- Outline the safety, efficacy and role of current and emerging treatments in addressing both skin and joint symptoms for psoriasis and psoriatic arthritis, including complex psoriatic disease presentations
- Apply a patient-centric, collaborative care and appropriate shared management model for treatment of psoriatic disease patients with both skin and joint symptoms and how to establish an integrated practice setting
The Chair for the 2022 symposium is Dr. George Michael Lewitt, M.D. from the Illinois Dermatology Institute. Participants will be able to claim up to 3 CME credits for this event.